ENCell Co., Ltd.

₩4,165As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:456070Healthcare
Country South Korea
PE (Fwd) •••
TSR 2Y CAGR (63.69%)
Div yield —
ROE (57.72%)
Biotechnology
Beta (5Y) 0.23
PE TTM —
TSR TTM (64.25%)
Mkt cap ₩45.94B
ROIC (26.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,668
12.07%
(35.76%)
Hold 2|10|10|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
84.65
82.80
83.32
84.83
10.37%
6.19%
(2.88%)
(1.93%)
Revenue₩B
3.959
4.011
3.910
3.845
(5.93%)
(1.95%)
(1.47%)
(3.96%)
Peers (US$33.87M)
Cap (US$)
PE
49.81M
—
23.93M
—
Capital
TTM
5Y
10Y
Leveragex
0.228
(0.224)
(0.165)
EBIT/Intx
1.713
0.133
0.163
Own earn%
(33.66)
(52.20)
(54.73)
Sh yield%
41.38
19.36
23.48
Owners
Insiders/Inst%
2.52
53.62
Short interest%
2.73
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
7–17
$1 testx
—
Incr. ROIC%
70